📰 Max Kates News
Max Kates News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Max Kates. Real-time updates on events, politics, business and more.
July 3, 2024
Right plate. For the 1st part in 7 years for how much sell our car to make sure its a winning return. A jack and top looks to in the one far as the missing from his collection the, the head of citizens, really and council of the fact that all the fun has appeals to the International Community to counter sponsors of the armies arrival at Rapid Support forces. I know that han has been addressing well the, the is the General Assembly within the last battle. He wont see you in the war, could spill o...
July 3, 2024
Driven motor steps down is charles fox news cole. And the end of an era for the controversial media mogul, the as the by done and ill media and separate this from the catalog of how the 1st direct piece tools as the by johns presidency said the totes were held in constructive and a peaceful atmosphere. No agreement has been reached yet, but they as a very official said, they presented the plans to re integrate the median population. The tools follow a ceasefire agreement which ended 24 hours of ...
January 30, 2024
Interim findings from the ongoing AMBASSADOR trial revealed a significant DFS benefit with adjuvant pembrolizumab but no overall survival benefit at this point.
October 7, 2023
Check out the Missouri-side highlights from Friday night’s high school football games around the Kansas City metro.
December 28, 2021
The National Institutes of Health (NIH) Revitalization Act of 1993 established guidelines for the inclusion of racial/ethnic minorities and women in clinical research. However, the reporting rate of such patient demographic data in clinical trials for BCG-unresponsive non-muscle invasive bladder cancer is not well characterized.
December 17, 2020
SUO 2020: Next Generation Clinical Trial Design BCG-Unresponsive NMIBC (UroToday.com) There have been several recent single-arm trials in the Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer (NMIBC) setting (Table 1). The first question that arises is whether these single-arm trials are enough or do we need to randomize patients for our future trials. As seen in Table 1, these treatments are given for a minimum of two years, requiring a high number of physician ...